Submit Deal

Announced

9 Sep 2024

EddingPharm to acquire Genor Biopharma for $395m.

Synopsis

EddingPharm, a pharmaceutical distribution company, agreed to acquire Genor Biopharma, a biopharma company, for $395m.

Principals

target

Genor Biopharma

bidder

Edding Group Company

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (2)

philip chan

Partner at Haiwen & Partners

Lawyer

target

Deal

n/a

Total Value

jackson tang

Partner at Haiwen & Partners

Lawyer

target

Deal

n/a

Total Value

Bidder Team (5)

ashlee wu

Partner at Kirkland & Ellis

Lawyer

bidder

Deal

n/a

Total Value

sherry fu

Registered Foreign Lawyer at Kirkland & Ellis

Lawyer

bidder

Deals

£ 355 M

Total Value

mengyu lu

Partner at Kirkland & Ellis

Lawyer

bidder

Deals

£ 104 M

Total Value

joey chau

Partner at Kirkland & Ellis

Lawyer

bidder

Deals

£ 8.77 B

Total Value

leo zhou

Registered Foreign Lawyer at Kirkland & Ellis

Lawyer

bidder

Deals

£ 2.96 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy